Litcius/Paper detail

Fluvoxamine, melatonin and COVID-19

George M. Anderson

2021Psychopharmacology21 citationsDOIOpen Access PDF

Topics & Concepts

Coronavirus disease 2019 (COVID-19)FluvoxamineMelatonin2019-20 coronavirus outbreakSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)VirologyEnvironmental scienceMedicineInternal medicineOutbreakInfectious disease (medical specialty)SerotoninDiseaseReceptorFluoxetinePharmacological Receptor Mechanisms and EffectsTryptophan and brain disordersEpilepsy research and treatment